Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Danish Study Links Type 1 Diabetes to Femoral Fractures

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting for age, only the association for T1D remains significant.

Glucose Excursions Drive CGM-A1c Discordance in Monitoring

Discordance between continuous glucose monitoring measures and A1c should not always be interpreted as measurement errors, according to a new study.

Primary Infertility Linked to Earlier Menopause Onset

Women with primary infertility undergo natural menopause earlier than women without infertility.

Exclusive-Cigna Drops Coverage Of GLP-1 Obesity Drugs for Its Own Employees

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee ⁠health plan effective July 1,...

Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.

How Cannabis Compounds May Help Create Weight-Loss Drugs

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and the pancreas.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting for age, only the association for T1D remains significant.

Discordance between continuous glucose monitoring measures and A1c should not always be interpreted as measurement errors, according to a new study.

Women with primary infertility undergo natural menopause earlier than women without infertility.

Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee ⁠health plan effective July 1,...

A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase 3 trial shows.

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and the pancreas.

News All Time

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Processed Meat May Raise Gastric and Oesophageal Cancer Risk

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Tirzepatide Raises Thyroid Risk in Certain At-Risk Patients

Patients with end-stage renal disease or preexisting thyroid disease are more likely to experience either a new thyroid problem or a worsening of their thyroid disease while on tirzepatide.

Is It Time to Talk to Patients About Bowel Hygiene?

Advising patients about bowel hygiene is on the rise as understanding grows about the multifaceted nature of GI disorders.

France Becomes First EU Country to Reimburse Anti-obesity Drugs, Minister Says

France will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a ⁠first for a European Union country, Health Minister Stephanie...

Use of Common Food Colours Tied to High Type 2 Diabetes Risk

A higher intake of several food colouring additives is associated with an increased risk of developing type 2 diabetes, an analysis of the French NutriNet-Santé cohort shows.

CVS Brings Back Coverage for Lilly's Obesity Drug Zepbound

CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered drugs and add the drugmaker's newly approved obesity pill, Foundayo, ⁠it said on...

PFAS Linked to Lower Bone Density in Youth

Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with lower bone mineral density in children and adolescents.

Indigenous-Led Study Targets Transplant Inequities

Researchers will document patient experiences and barriers to care across British Columbia, Alberta, and Saskatchewan.

Weight-Loss Pill Approval Highlights Important Role of PCPs

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity medications.

Thyroid Aging Patterns Can Predict Mortality Risk

Thyroid function changes modestly with age but shows greater variability from age 65 years onward, and distinct patterns of thyroid function change are linked to an increased risk for mortality.

EMA Panel Backs Weekly Hormone for Child Growth Disorders

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

Curcumin Supplementation May Help Ease Depression

Curcumin, the primary active compound in the spice turmeric, was associated with significant reduction in depressive symptoms in new research that has been characterized as ‘clinically meaningful.’

Recommended News For You

Liver cancer cells under pressure: Compression can spark invasion, drug resistance and altered gene activity

Women who miss their first mammogram face higher risk of breast cancer death, study finds

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Team finds broken 'brake' on cancer mutation machine.

Early palliative care billing up from 2010 to 2019 for advanced cancer

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Kate Middleton and Remission: Oncologists Weigh In

Recommended Articles For You

Predicting Incidental Prostate Cancer in BPH Surgery Patients 

What is Hemorrhagic Cystitis and How to Manage its Symptoms 

Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NIH research cuts leave cancer patient facing hard choice

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Year in Review: Multiple Myeloma

4.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

5.

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

1.

Unveiling the Hidden Benefits of Lymphedema Treatment

2.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

3.

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making

4.

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership

5.

Understanding Apoplexy: Symptoms, Causes, and Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot